VTGN
VistaGen Therapeutics Inc
NASDAQ: VTGN · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.94% today
Updated 2026-04-30
Market cap
$23.64M
P/E ratio
—
P/S ratio
29.96x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$0 – $5
Volume
0.7M
VistaGen Therapeutics Inc (VTGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.34M | $200400.00 | $0.00 | $-135000.00 | $0.00 | $1.25M | $0.00 | $0.00 | $334000.00 | $1.09M | $1.11M | $-227300.00 | $1.06M | $486000.00 |
| Revenue growth (YoY) | — | — | — | — | — | -85.1% | -100.0% | — | +100.0% | — | -100.0% | — | — | +226.2% | +1.8% | -120.5% | +568.1% | -54.3% |
| Cost of revenue | — | — | — | — | $10.34M | $6.96M | $4.97M | $0.00 | $53500.00 | $11.44M | $80700.00 | $91200.00 | $103100.00 | — | $815200.00 | $509800.00 | $568000.00 | $635000.00 |
| Gross profit | — | — | — | — | $1.34M | $200400.00 | $0.00 | $-135000.00 | $0.00 | $1.25M | $0.00 | $-91200.00 | $-103100.00 | $1.09M | $1.11M | $-227300.00 | $1.06M | $486000.00 |
| Gross margin | — | — | — | — | 100.0% | 100.0% | — | 100.0% | — | 100.0% | — | — | -30.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | — | — | — | — | $5.39M | $3.43M | $2.48M | $2.43M | $3.93M | $5.20M | $7.76M | $17.10M | $13.33M | $11.93M | $35.41M | $44.38M | $20.02M | $39.38M |
| SG&A | $4784.00 | $16350.00 | $21540.00 | $8390.00 | $4.36M | $3.56M | $2.55M | $4.25M | $13.92M | $5.87M | $6.44M | $7.43M | $6.60M | $7.10M | $10.45M | $14.66M | $14.06M | $17.08M |
| Operating income | $-4784.00 | $-16386.00 | $-21968.00 | $-8946.00 | $-9.04M | $-6.79M | $-5.03M | $-6.78M | $-17.85M | $-10.25M | $-14.20M | $-24.56M | $-19.97M | $-17.93M | $-47.78M | $-59.27M | $-33.02M | $-55.97M |
| Operating margin | — | — | — | — | -673.8% | -3389.8% | — | 5020.1% | — | -819.9% | — | — | -5980.4% | -1646.1% | -4308.7% | 26074.8% | -3103.5% | -11517.1% |
| EBITDA | $-4784.00 | $-16350.00 | $-21540.00 | $-6.32M | $-10.27M | $-11.85M | $-4.97M | $-6.72M | $-17.80M | $-9.77M | $-14.12M | $-24.47M | $-20.65M | $-17.44M | $-47.05M | $-58.74M | $-32.45M | $-55.34M |
| EBITDA margin | — | — | — | — | -765.0% | -5910.8% | — | 4976.3% | — | -781.3% | — | — | -6183.6% | -1600.8% | -4242.8% | 25841.1% | -3050.1% | -11386.4% |
| EBIT | $-4784.00 | $-16386.00 | $-21968.00 | $-6.32M | $-10.31M | $-11.88M | $-5.03M | $-6.78M | $-17.85M | $-9.82M | $-14.20M | $-24.56M | $-20.76M | $-17.92M | $-47.76M | $-59.27M | $-33.02M | $-55.97M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $1.89M | $1.00M | $1.56M | $4.62M | $777000.00 | $5000.00 | $8900.00 | $8000.00 | $15000.00 | $13000.00 | $232000.00 | $23000.00 | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4754.00 | $-16416.00 | $-21998.00 | $-8976.00 | $-12.21M | $-12.89M | $-2.97M | $-13.89M | $-47.22M | $-10.26M | $-14.35M | $-24.59M | $-20.77M | $-17.93M | $-47.76M | $-59.25M | $-29.36M | $-51.42M |
| Net income growth (YoY) | — | -245.3% | -34.0% | +59.2% | -135923.8% | -5.5% | +77.0% | -367.9% | -240.1% | +78.3% | -39.9% | -71.4% | +15.5% | +13.7% | -166.3% | -24.0% | +50.4% | -75.1% |
| Profit margin | — | — | — | — | -909.7% | -6430.5% | — | 10285.8% | — | -820.4% | — | — | -6219.8% | -1646.1% | -4307.2% | 26065.9% | -2759.6% | -10579.8% |